Page last updated: 2024-08-16

ritanserin and mdl 28133a

ritanserin has been researched along with mdl 28133a in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Humphreys, TM; Schmidt, CJ; Sorensen, SM; Taylor, VL1
Bruns, GC; Dage, RC; Hsieh, CP; Sakai, K1

Other Studies

2 other study(ies) available for ritanserin and mdl 28133a

ArticleYear
5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:2

    Topics: Action Potentials; Amphetamines; Animals; Apomorphine; Carbidopa; Dopamine; Dopamine Antagonists; Fenclonine; Levodopa; Male; Neurons; Piperidines; Rats; Rats, Inbred Strains; Ritanserin

1992
Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs.
    Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:5

    Topics: Administration, Oral; Animals; Biological Availability; Blood Platelets; Blood Pressure; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Therapy, Combination; Electric Stimulation; Female; Heart Rate; Heparin; In Vitro Techniques; Male; Piperidines; Platelet Aggregation; Ritanserin; Serotonin; Serotonin Antagonists; Streptokinase

1994